The exterior of the Drug and Food Administration headquarters is located in White Oak, Md.
Al Drago | CQ Roll Call | Getty Images
Two senior Food and Drug Administration officials responsible for reviewing Covid-19 vaccine applications are leaving the federal agency this fall, an agency spokesman confirmed Tuesday.
Marion Gruber, director of the FDA’s Office of Vaccine Research and Review, and deputy director Phil Krause will leave the agency in October and November, respectively, according to a letter shared with CNBC by the FDA spokeswoman. Stephanie Caccomo.
“Many thanks to Marion and Phil for everything they have contributed and continue to contribute to the agency and many thanks to each of you for everything you do every day,” Dr. Peter Marks, FDA vaccine regulator. the letter.
The news was previously reported by biotechnology website BioCentury.
His announced plans to leave come as the Biden administration prepares to begin offering Covid vaccines to the general public in the week of September 20th. in reinforcers still.
Endpoints News, a biotech industry publication, reported that officials are leaving because they are frustrated that the Centers for Disease Control and Prevention and its advisory committee are involved in decisions they believe should be made by the FDA.
The last time was when the White House stepped in to the agency to make reinforcements, according to Endpoints News, citing a former FDA leader.